blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2136788

EP2136788 - CANCER CELL TARGETING USING NANOPARTICLES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.08.2012
Database last updated on 24.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU
published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Bind Biosciences, Inc.
64 Sidney Street
Cambridge, MA 02139 / US
[2010/01]
Inventor(s)01 / ZALE, Stephen, E.
101 Binney Street
Cambridge, MA 02142 / US
02 / ALI, Mir Mukkaram
53 Cedar Street, Apt. 3205
Woburn, MA 01801 / US
 [2010/01]
Representative(s)Harris, Jennifer Lucy, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2010/01]Harris, Jennifer Lucy, et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date08744752.031.03.2008
[2010/01]
WO2008US58873
Priority number, dateUS20070976197P28.09.2007         Original published format: US 976197 P
[2011/43]
Former [2010/01]WO2007US0079230.03.2007
US20070976197P28.09.2007
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008121949
Date:09.10.2008
Language:EN
[2008/41]
Type: A1 Application with search report 
No.:EP2136788
Date:30.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2008 takes the place of the publication of the European patent application.
[2009/53]
Type: B1 Patent specification 
No.:EP2136788
Date:26.10.2011
Language:EN
[2011/43]
Search report(s)International search report - published on:US09.10.2008
(Supplementary) European search report - dispatched on:EP07.05.2010
ClassificationIPC:A61K9/14, B82B1/00, A61P35/00, A61K9/51, A61K31/337
[2010/23]
CPC:
A61K9/5153 (EP,US); A61K9/1647 (US); A61K31/136 (EP,US);
A61K31/197 (EP,US); A61K31/337 (EP,US); A61K31/704 (EP,US);
A61K47/34 (US); A61K47/542 (EP,US); A61K47/60 (EP,US);
A61K47/6935 (EP,US); A61K47/6937 (EP,US); A61K9/146 (US);
A61K9/5192 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P13/08 (EP); A61P25/00 (EP); A61P35/00 (EP);
B82Y5/00 (EP,US); C07C275/16 (EP,US); C07C275/24 (EP,US);
C08G63/664 (EP,US); C08G63/6852 (EP,US); C08G63/6922 (EP,US);
Y10S977/904 (EP,US); Y10S977/905 (EP,US); Y10S977/906 (EP,US);
Y10S977/911 (EP,US); Y10S977/915 (EP,US) (-)
Former IPC [2010/01]A61K9/14, B82B1/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/01]
Extension statesAL21.05.2009
BA21.05.2009
MK21.05.2009
RS21.05.2009
TitleGerman:KREBSZELLEN-TARGETING MIT NANOPARTIKELN[2010/01]
English:CANCER CELL TARGETING USING NANOPARTICLES[2010/01]
French:CIBLAGE DE CELLULES CANCÉREUSES UTILISANT DES NANOPARTICULES[2010/01]
Entry into regional phase21.05.2009National basic fee paid 
21.05.2009Search fee paid 
21.05.2009Designation fee(s) paid 
21.05.2009Examination fee paid 
Examination procedure20.05.2009Amendment by applicant (claims and/or description)
21.05.2009Examination requested  [2009/53]
31.03.2011Despatch of a communication from the examining division (Time limit: M04)
01.04.2011Reply to a communication from the examining division
03.05.2011Communication of intention to grant the patent
12.08.2011Fee for grant paid
12.08.2011Fee for publishing/printing paid
Divisional application(s)EP11186037.5  / EP2436376
EP13162786.1  / EP2644192
EP13162789.5  / EP2644594
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.03.2011
Opposition(s)27.07.2012No opposition filed within time limit [2012/40]
Fees paidRenewal fee
25.03.2010Renewal fee patent year 03
29.03.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.03.2008
AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
MT26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
LU31.03.2012
MC31.03.2012
[2014/34]
Former [2014/27]AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
MT26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
LU31.03.2012
MC31.03.2012
Former [2014/21]AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
MT26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
TR26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
MC31.03.2012
Former [2013/35]AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
MT26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
MC31.03.2012
Former [2013/29]AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
FI26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
MC31.03.2012
Former [2013/07]AT26.10.2011
CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
MC31.03.2012
Former [2012/47]CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
MC31.03.2012
Former [2012/36]CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
RO26.10.2011
SI26.10.2011
SK26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
Former [2012/35]CY26.10.2011
CZ26.10.2011
DK26.10.2011
EE26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
SI26.10.2011
BG26.01.2012
NO26.01.2012
IS26.02.2012
Former [2012/34]CY26.10.2011
CZ26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
SI26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/28]CY26.10.2011
HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
SI26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/27]HR26.10.2011
LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
SI26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/26]LT26.10.2011
LV26.10.2011
NL26.10.2011
PL26.10.2011
SI26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/24]LT26.10.2011
LV26.10.2011
NL26.10.2011
SI26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/21]LT26.10.2011
NO26.01.2012
IS26.02.2012
Former [2012/20]LT26.10.2011
NO26.01.2012
Documents cited:Search[A]WO2007034479  (YISSUM RES DEV CO [IL], et al) [A] 1-9 * example 3 ** claims 1-25 *
International search[A]US6902743  (SETTERSTROM JEAN A [US], et al);
 [A]US2005136258  (NIE SHUMING [US], et al);
 [Y]US2005256071  (DAVIS MARK E [US]);
 [A]US2006002971  (SALTZMAN WILLIAM M [US], et al);
 [A]US2006002852  (SALTZMAN WILLIAM M [US], et al);
 [A]US2007041901  (DIENER JOHN L [US], et al);
 [Y]US2007053845  (SENGUPTA SHILADITYA [US], et al);
 [X]  - ZHOU ET AL., "NAAG Peptidase Inhibitors and Their Potential for Diagnosis and Therapy", NATURE REVIEWS: DRUG DISCOVERY, (200512), vol. 4, pages 1015 - 1026, XP002514725

DOI:   http://dx.doi.org/10.1038/nrd1903
 [Y]  - FOSS ET AL., "Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: in Vivo Imaging in Experimental Models of Prostate Cancer", CLINICAL CANCER RESEARCH, (200506), vol. 11, no. 11, pages 4022 - 4028, XP008109807

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-04-2690
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.